S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses

Journal of Pharmacology and Experimental Therapeutics

Volumn 316, Issue 3, 2006, Pages 1229-1237

  Fu, Yun Feng ^a   Wang, Jun Xia ^a   Zhao, Yang ^a   Yang, Yang ^b   Tang, Wei ^a   Ni, Jia ^a   Zhu, Yi Na ^a   Zhou, Ru ^a   He, Pei Lan ^a   Li, Chuan ^a   Li, Xiao Yu ^a   Yang, Yi Fu ^a   Lawson, Brian R ^c   Zuo, Jian Ping ^a,b,d  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c Diazyme Laboratories   (United States)

^d SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSYLHOMOCYSTEINASE; ADENOSYLHOMOCYSTEINASE INHIBITOR; DZ 2002; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; INTERLEUKIN 2; INTERLEUKIN 4; METHYL 4 (ADENIN 9 YL) 2 HYDROXYBUTANOATE; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADENINE; ADENOSYLHOMOCYSTEINASE; ANIMALS; ANTIBODY FORMATION; BUTYRIC ACIDS; CYTOKINES; ENZYME INHIBITORS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; S-ADENOSYLHOMOCYSTEINE;

EID: 33644770348     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.093369     Document Type: Article

References (31)

1. Abbas AK, Murphy KM, and Sher A (1996) Functional diversity of helper T lymphocytes. Nature (Lond) 383:787-793.
2. Boger RH, Bode-Boger SM, Sydow K, Heistad DD, and Lentz SR (2000a) Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler Thromb Vasc Biol 20:1557-1564.
3. Boger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, and Bode-Boger SM (2000b) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S- adenosylmethionine-dependent methyltransferases. Circ Res 87:99-105.
4. Burstein HJ and Abbas AK (1993) In vivo role of interleukin 4 in T cell tolerance induced by aqueous protein antigen. J Exp Med 177:457-463.
5. Desai DM, Newton ME, Kadlecek T, and Weiss A (1990) Stimulation of the phosphatidylinositol pathway can induce T-cell activation. Nature (Lond) 348:66-69.
6. Feng YH, Zhou WL, Wu QL, Li XY, Zhao WM, and Zou JP (2002) Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol Sin 23:893-897.
7. Fonlupt P, Roche M, Cronenberger L, and Pacheco H (1979a) Action of S-adenosyl-L-homocysteine on the metabolism of dopamine, norepinephrine and serotonin in rat brain. Arch Int Pharmacodyn Ther 240:35-44.
8. Fonlupt P, Roche M, Cronenberger L, and Pacheco H (1979b) Activation by S-adenosylhomocysteine of norepinephrine and serotonin in vitro uptake in synaptosomal preparations from rat brain. Experientia 35:1089-1090.
9. Fu YF, Xiong Y, and Guo Z (2005) A reduction of endogenous asymmetric dimethylarginine contributes to the effect of captopril on endothelial dysfunction induced by homocysteine in rats. Eur J Pharmacol 508:167-175.
10. German DC, Bloch CA, and Kredich NM (1983) Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells. J Biol Chem 258:10997-11003.
11. Gharib A, Sarda N, Chabannes B, and Pacheco H (1985) Pharmacokinetics and metabolism of S-adenosyl-L-homocysteine, in rats and dog. Eur J Drug Metab Pharmacokinet 10:289-291.
12. Isakson PC, Pure E, Vitetta ES, and Krammer PH (1982) T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J Exp Med 155:734-748.
13. Konarska MM, Padgett RA, and Sharp PA (1984) Recognition of cap structure in splicing in vitro of mRNA precursors. Cell 38:731-736.
14. Lernmark A (2001) Series introduction: autoimmune diseases: are markers ready for prediction? J Clin Investig 108:1091-1096.
15. Mowen KA, Schurter BT, Fathman JW, David M, and Glimcher LH (2004) Arginine methylation of NIP45 modulates cytokine gene expression in effector T lymphocytes. Mol Cell 15:559-571.
16. Pike MC and DeMeester CA (1988) Inhibition of phosphoinositide metabolism in human polymorphonuclear leukocytes by S-adenosylhomocysteine. J Biol Chem 263:3592-3599.
17. Richard S, Morel M, and Cleroux P (2005) Arginine methylation regulates IL-2 gene expression: a role for PRMT5. Biochem J 388:379-386.
18. Saso Y, Conner EM, Teegarden BR, and Yuan CS (2001) S-Adenosyl-L- homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. J Pharmacol Exp Ther 296:106-112.
19. + T cells. Annu Rev Immunol 12:635-673.
20. She QB, Nagao I, Hayakawa T, and Tsuge H (1994) A simple HPLC method for the determination of S-adenosylmethionine and S-adenosylhomocysteine in rat tissues: the effect of vitamin B6 deficiency on these concentrations in rat liver. Biochem Biophys Res Commun 205:1748-1754.
21. Tan EW, Perez-Sala D, Canada FJ, and Rando RR (1991) Identifying the recognition unit for G protein methylation. J Biol Chem 266:10719-10722.
22. Theofilopoulos AN and Lawson BR (1999) Tumour necrosis factor and other cytokines in murine lupus. Ann Rheum Dis 58:49-51.
23. Wang W, Kramer PM, Yang S, Pereira MA, and Tao L (2001) Reversed-phase high-performance liquid chromatography procedure for the simultaneous determination of S-adenosyl-L-methionine and S-adenosyl-L-homocysteine in mouse liver and the effect of methionine on their concentrations. J Chromatogr B Biomed Sci Appl 762:59-65.
24. Wolos JA, Frondorf KA, Babcock GF, Stripp SA, and Bowlin TL (1993a) Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses. Cell Immunol 149:402-408.
25. Wolos JA, Frondorf KA, Davis GF, Jarvi ET, McCarthy JR, and Bowlin TL (1993b) Selective inhibition of T cell activation by an inhibitor of S-adenosyl-Lhomocysteine hydrolase. J Immunol 150:3264-3273.
26. Wolos JA, Frondorf KA, and Esser RE (1993c) Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis. J Immunol 151:526-534.
27. Wu QL, Fu YF, Zhou WL, Wang JX, Feng YH, Liu J, Xu JY, He PL, Zhou R, Tang W, et al. (2005) Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression. J Pharmacol Exp Ther 313:705-711.
28. Yoshino S, Yamaki K, Li X, Sai T, Yanagisawa R, Takano H, Taneda S, Hayashi H, and Mori Y (2004) Prenatal exposure to bisphenol A up-regulates immune responses, including T helper 1 and T helper 2 responses, in mice. Immunology 112:489-495.
29. Yoshino S, Yamaki K, Yanagisawa R, Takano H, Hayashi H, and Mori Y (2003) Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells and TH1 and TH2 immune responses in mice. Br J Pharmacol 138:1271-1276.
30. Yuan CS, Liu S, Wnuk SF, Robins MJ, and Borchardt RT (1994) Mechanism of inactivation of S-adenosylhomocysteine hydrolase by (E)-5′,6′- didehydro-6′-deoxy-6′-halohomoadenosines. Biochemistry 33:3758-3765.
31. Yuan CS, Saso Y, Lazarides E, Borchardt RT, and Robins MJ (1999) Recent advances in S-adenosyl-L-homocysteine hydrolase inhibitors and their potential clinical applications. Exp Opin Ther Patents 9:1197-1206.